Overview Bunionectomy Trial With GRT6005 Status: Completed Trial end date: 2009-10-01 Target enrollment: Participant gender: Summary The purpose of the trial is to determine whether the new centrally acting analgesic is effective in comparison to placebo and an active comparator (morphine). Phase: Phase 2 Details Lead Sponsor: Grünenthal GmbHTris Pharma, Inc.Treatments: AnalgesicsMorphine